Login / Signup

KDM8 epigenetically controls cardiac metabolism to prevent initiation of dilated cardiomyopathy.

Abdalla AhmedJibran Nehal SyedLijun ChiYaxu WangCarmina Perez-RomeroDorothy LeeEtri KocaqiAmalia CaballeroJielin YangQuetzalcoatl Escalante-CovarrubiasAkihiko IshimuraTakeshi SuzukiLorena Aguilar-ArnalGerard Bryan GonzalesKyoung-Han KimPaul Delgado Olguin
Published in: Nature cardiovascular research (2023)
Cardiac metabolism is deranged in heart failure, but underlying mechanisms remain unclear. Here, we show that lysine demethylase 8 (Kdm8) maintains an active mitochondrial gene network by repressing Tbx15 , thus preventing dilated cardiomyopathy leading to lethal heart failure. Deletion of Kdm8 in mouse cardiomyocytes increased H3K36me2 with activation of Tbx15 and repression of target genes in the NAD + pathway before dilated cardiomyopathy initiated. NAD + supplementation prevented dilated cardiomyopathy in Kdm8 mutant mice, and TBX15 overexpression blunted NAD + -activated cardiomyocyte respiration. Furthermore, KDM8 was downregulated in human hearts affected by dilated cardiomyopathy, and higher TBX15 expression defines a subgroup of affected hearts with the strongest downregulation of genes encoding mitochondrial proteins. Thus, KDM8 represses TBX15 to maintain cardiac metabolism. Our results suggest that epigenetic dysregulation of metabolic gene networks initiates myocardium deterioration toward heart failure and could underlie heterogeneity of dilated cardiomyopathy.
Keyphrases